Showing results (101-110 of 191) with videos related to

Sort By:
Pageof 20
Chemmedchem|October 31, 2022
Imaging of K<sub>Ca</sub> 3.1 Channels in Tumor Cells with PET and Small-Molecule Fluorescent ProbesInsa Thale, Sarah Maskri, Lucie Grey, et al.
Experimental Neurology|September 11, 2012
The TASK1 channel inhibitor A293 shows efficacy in a mouse model of multiple sclerosisStefan Bittner, Marcella A Bauer, Petra Ehling, et al.
Medicine and Science in Sports and Exercise|January 5, 2011
Carotid and peripheral atherosclerosis in male marathon runnersKnut Kröger, Nils Lehmann, Lisa Rappaport, et al.
Biochemical Pharmacology|August 16, 2017
Doxorubicin enhances oxysterol levels resulting in a LXR-mediated upregulation of cardiac cholesterol transportersJudith V Monzel, Thomas Budde, Henriette E Meyer Zu Schwabedissen, et al.
Annals of Neurology|June 29, 2010
Upregulation of K2P5.1 potassium channels in multiple sclerosisStefan Bittner, Nicole Bobak, Alexander M Herrmann, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 10, 2009
Postnatal expression pattern of HCN channel isoforms in thalamic neurons: relationship to maturation of thalamocortical oscillationsTatyana Kanyshkova, Matthias Pawlowski, Patrick Meuth, et al.
Journal of Pharmaceutical Sciences|May 19, 2011
Acute exposure to doxorubicin results in increased cardiac P-glycoprotein expressionThomas Budde, Jeanette Haney, Sandra Bien, et al.
Neurobiology of Disease|October 22, 2008
The neuroprotective impact of the leak potassium channel TASK1 on stroke development in miceSven G Meuth, Christoph Kleinschnitz, Tilman Broicher, et al.
ACS Pharmacology & Translational Science|September 19, 2025
Visualization of K<sub>Ca</sub>3.1 Channels in Tumor Cells by Optimized Senicapoc-Bodipy ConjugatesInsa Thale, Joana Massa, Elke Naß, et al.
Pageof 20